Atli FH, Manduz S., Katrancioglu N., et al. eNOS G894T polymorphism and abdominal aortic aneurysms. Angiology. 2009 [Epub ahead of print].
2.
McCormick ML , Gavrila D., Weintraub NLRole of oxidative stress in the pathogenesis of abdominal aortic aneurysms . Arterioscler Thromb Vasc Biol. 2007;27(3): 461-469.
3.
Miller FJ Jr , Sharp WJ , Fang X., Oberley LW, Oberley TD, Weintraub NLOxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol. 2002;22(4):560-565.
4.
Xiong W., Mactaggart J., Knispel R., et al. Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 2009;202(1): 128-134.
5.
Paraskevas KI , Tzovaras AA, Briana DD, Mikhailidis DPEmerging indications for statins: a pluripotent family of agents with several potential applications. Curr Pharm Des. 2007;13(35):3622-3636.
6.
Athyros VG, Kakafika AI, Tziomalos K., Karagiannis A., Mikhailidis DPPleiotropic effects of statins-clinical evidence. Curr Pharm Des. 2009;15(5):479-489.
7.
Steinmetz EF , Buckley C., Shames ML, et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg. 2005;241(1):92-101.
8.
Kalyanasundaram A., Elmore JR, Manazer JR, et al. Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg. 2006 ;43(1):117-124.
9.
Paraskevas KI , Liapis CD, Hamilton G., Mikhailidis DPAre statins an option in the management of abdominal aortic aneurysms? Vasc Endovascular Surg. 2008;42(2): 128-134.
10.
Paraskevas KI, Liapis CD, Hamilton G., Mikhailidis DPCan statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg. 2006;32(3):286-293.
11.
Saratzis A. , Saratzis N., Melas N., Kiskinis D.Pharmacotherapy before and after endovascular repair of abdominal aortic aneurysms. Curr Vasc Pharmacol . 2008;6(4):240-249.
